Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat

Restricted access

✓ The present study was undertaken to determine if estrogens protect female rats from the neurodegenerative effects of middle cerebral artery (MCA) occlusion. The rats were ovariectomized and 7 or 8 days later various estrogen preparations were administered before or after MCA occlusion. Pretreatment with 17β-estradiol (17β-E2) or a brain-targeted 17β-E2 chemical delivery system (CDS) decreased mortality from 65% in ovariectomized rats to 22% in 17β-E2—treated and 16% in 17β-E2 CDS—treated rats. This marked reduction in mortality was accompanied by a reduction in the ischemic area of the brain from 25.6 ± 5.7% in the ovariectomized rats to 9.8 ± 4% and 9.1 ± 4.2% in the 17β-E2—implanted and the 17β-E2 CDS—treated rats, respectively. Similarly, pretreatment with the presumed inactive estrogen, 17α-estradiol, reduced mortality from 36 to 0% and reduced the ischemic area by 55 to 81%. When administered 40 or 90 minutes after MCA occlusion, 17β-E2 CDS reduced the area of ischemia by 45 to 90% or 31%, respectively. In summary, the present study provides the first evidence that estrogens exert neuroprotective effects in an animal model of ischemia and suggests that estrogens may be a useful therapy to protect neurons against the neurodegenerative effects of stroke.

Article Information

Contributor Notes

Address reprint requests to: James W. Simpkins, Ph.D., College of Pharmacy, University of Florida, Gainesville, Florida 32610. email: simpkins@cop.health.ufl.edu.
Headings
References
  • 1.

    Bederson JBPitts LHGermano IMet al: Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 17:130413081986Bederson JB Pitts LH Germano IM et al: Evaluation of 235-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 17:1304–1308 1986

    • Search Google Scholar
    • Export Citation
  • 2.

    Behl CWidmann MTrapp Tet al: 17-β estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun 216:4734821995Behl C Widmann M Trapp T et al: 17-β estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun 216:473–482 1995

    • Search Google Scholar
    • Export Citation
  • 3.

    Benveniste HDrejer JSchousboe Aet al: Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem 43:136913741984Benveniste H Drejer J Schousboe A et al: Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem 43:1369–1374 1984

    • Search Google Scholar
    • Export Citation
  • 4.

    Bishop JSimpkins JW: Estradiol treatment increases viability of glioma and neuroblastoma cells in vitro. Mol Cell Neurosci 5:3033081994Bishop J Simpkins JW: Estradiol treatment increases viability of glioma and neuroblastoma cells in vitro. Mol Cell Neurosci 5:303–308 1994

    • Search Google Scholar
    • Export Citation
  • 5.

    Brewster MESimpkins JWBodor N: Brain-targeted delivery of estrogens. Rev Neurosci 11:2412851990Brewster ME Simpkins JW Bodor N: Brain-targeted delivery of estrogens. Rev Neurosci 11:241–285 1990

    • Search Google Scholar
    • Export Citation
  • 6.

    Brewster MESimpkins JWHara MSet al: The potential use of cyclodextrins in parenteral formulations. J Parent Sci Technol 43:2312401989Brewster ME Simpkins JW Hara MS et al: The potential use of cyclodextrins in parenteral formulations. J Parent Sci Technol 43:231–240 1989

    • Search Google Scholar
    • Export Citation
  • 7.

    Chan PH: Oxygen radicals in focal cerebral ischemia. Brain Pathol 4:59651994Chan PH: Oxygen radicals in focal cerebral ischemia. Brain Pathol 4:59–65 1994

    • Search Google Scholar
    • Export Citation
  • 8.

    Choi DW: Excitotoxic cell death. J Neurobiol 23:126112761992Choi DW: Excitotoxic cell death. J Neurobiol 23:1261–1276 1992

  • 9.

    Choi DW: Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:6236341988Choi DW: Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623–634 1988

    • Search Google Scholar
    • Export Citation
  • 10.

    Clark JHWilliams MUpchurch Set al: Effects of estradiol-17α on nuclear occupancy of the estrogen receptor, stimulation of nuclear type II sites and uterine growth. J Ster Biochem 16:3233281982Clark JH Williams M Upchurch S et al: Effects of estradiol-17α on nuclear occupancy of the estrogen receptor stimulation of nuclear type II sites and uterine growth. J Ster Biochem 16:323–328 1982

    • Search Google Scholar
    • Export Citation
  • 11.

    Dugan LLChoi DW: Excitotoxicity, free radicals, and cell membrane changes. Am Neurol Assoc 35 (Suppl):S17S211994Dugan LL Choi DW: Excitotoxicity free radicals and cell membrane changes. Am Neurol Assoc 35 (Suppl):S17–S21 1994

    • Search Google Scholar
    • Export Citation
  • 12.

    Estes KSBrewster MESimpkins JWet al: A novel redox system for CNS-directed delivery of estradiol causes sustained LH suppression in castrate rats. Life Sci 40:132713341987Estes KS Brewster ME Simpkins JW et al: A novel redox system for CNS-directed delivery of estradiol causes sustained LH suppression in castrate rats. Life Sci 40:1327–1334 1987

    • Search Google Scholar
    • Export Citation
  • 13.

    Falkeborn MPersson ITerént Aet al: Hormone replacement therapy and the risk of stroke. Follow-up of a population-based cohort in Sweden. Arch Intern Med 153:120112091993Falkeborn M Persson I Terént A et al: Hormone replacement therapy and the risk of stroke. Follow-up of a population-based cohort in Sweden. Arch Intern Med 153:1201–1209 1993

    • Search Google Scholar
    • Export Citation
  • 14.

    Finucane FFMadans JHBush TLet al: Decreased risk of stroke among postmenopausal hormone users. Results from a national cohort. Arch Intern Med 153:73791993Finucane FF Madans JH Bush TL et al: Decreased risk of stroke among postmenopausal hormone users. Results from a national cohort. Arch Intern Med 153:73–79 1993

    • Search Google Scholar
    • Export Citation
  • 15.

    Ginsberg MDBusto R: Rodent models of cerebral ischemia. Stroke 20:162716421989Ginsberg MD Busto R: Rodent models of cerebral ischemia. Stroke 20:1627–1642 1989

    • Search Google Scholar
    • Export Citation
  • 16.

    Goodman YBruce AJCheng B: Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid β-peptide toxicity in hippocampal neurons. J Neurochem 66:183618441996Goodman Y Bruce AJ Cheng B: Estrogens attenuate and corticosterone exacerbates excitotoxicity oxidative injury and amyloid β-peptide toxicity in hippocampal neurons. J Neurochem 66:1836–1844 1996

    • Search Google Scholar
    • Export Citation
  • 17.

    Gotoh OMohamed AAMcCulloch Jet al: Nimodipine and the haemodynamic and histopathological consequences of middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 6:3213311986Gotoh O Mohamed AA McCulloch J et al: Nimodipine and the haemodynamic and histopathological consequences of middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 6:321–331 1986

    • Search Google Scholar
    • Export Citation
  • 18.

    Green PSBishop JSimpkins JW: 17α-estradiol exerts neuroprotective effects on SK-N-SH cells. J Neurosci 17:5115151997Green PS Bishop J Simpkins JW: 17α-estradiol exerts neuroprotective effects on SK-N-SH cells. J Neurosci 17:511–515 1997

    • Search Google Scholar
    • Export Citation
  • 19.

    Green PSGridley KESimpkins JW: Estradiol protects against β-amyloid (25–35)-induced toxicity in SK-N-SH human neuroblastoma cells. Neurosci Lett 218:1651681996Green PS Gridley KE Simpkins JW: Estradiol protects against β-amyloid (25–35)-induced toxicity in SK-N-SH human neuroblastoma cells. Neurosci Lett 218:165–168 1996

    • Search Google Scholar
    • Export Citation
  • 20.

    Huggins CJensen EVCleveland AS: Chemical structure of steroids in relation to promotion of growth of the vagina and uterus of the hypophysectomized rat. J Exp Med 100:2252411954Huggins C Jensen EV Cleveland AS: Chemical structure of steroids in relation to promotion of growth of the vagina and uterus of the hypophysectomized rat. J Exp Med 100:225–241 1954

    • Search Google Scholar
    • Export Citation
  • 21.

    Hurn PDLittleton-Kearney MTKirsch JRet al: Postischemic cerebral blood flow recovery in the female: effect of 17β-estradiol. J Cereb Blood Flow Metab 15:6666721995Hurn PD Littleton-Kearney MT Kirsch JR et al: Postischemic cerebral blood flow recovery in the female: effect of 17β-estradiol. J Cereb Blood Flow Metab 15:666–672 1995

    • Search Google Scholar
    • Export Citation
  • 22.

    Korenman SG: Comparative binding affinity of estrogens and its relation to estrogenic potency. Steroids 13:1631771969Korenman SG: Comparative binding affinity of estrogens and its relation to estrogenic potency. Steroids 13:163–177 1969

    • Search Google Scholar
    • Export Citation
  • 23.

    Manolio TAFurberg CDShemanski Let al: Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women. Circulation 88:216321711993Manolio TA Furberg CD Shemanski L et al: Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women. Circulation 88:2163–2171 1993

    • Search Google Scholar
    • Export Citation
  • 24.

    Menzies SAHoff JTBetz AL: Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model. Neurosurgery 31:1001071992Menzies SA Hoff JT Betz AL: Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model. Neurosurgery 31:100–107 1992

    • Search Google Scholar
    • Export Citation
  • 25.

    Mohamed AAGotoh OGraham DIet al: Effect of pretreatment with the calcium antagonist nimodipine on local cerebral blood flow and histopathology after middle cerebral artery occlusion. Ann Neurol 18:7057111985Mohamed AA Gotoh O Graham DI et al: Effect of pretreatment with the calcium antagonist nimodipine on local cerebral blood flow and histopathology after middle cerebral artery occlusion. Ann Neurol 18:705–711 1985

    • Search Google Scholar
    • Export Citation
  • 26.

    Morley PHogan MJHakim AM: Calcium-mediated mechanisms of ischemic injury and protection. Brain Pathol 4:37471994Morley P Hogan MJ Hakim AM: Calcium-mediated mechanisms of ischemic injury and protection. Brain Pathol 4:37–47 1994

    • Search Google Scholar
    • Export Citation
  • 27.

    Paganini-Hill A: Estrogen replacement therapy and stroke. Progr Cardiovasc Dis 38:2232421995Paganini-Hill A: Estrogen replacement therapy and stroke. Progr Cardiovasc Dis 38:223–242 1995

    • Search Google Scholar
    • Export Citation
  • 28.

    Paganini-Hill ARoss RKHenderson BE: Postmenopausal oestrogen treatment and stroke: a prospective study. Br Med J 297:5195221988Paganini-Hill A Ross RK Henderson BE: Postmenopausal oestrogen treatment and stroke: a prospective study. Br Med J 297:519–522 1988

    • Search Google Scholar
    • Export Citation
  • 29.

    Rahimy MHAnderson WRBrewster MEet al: The effects of a brain-enhanced estradiol delivery system on testosterone and androgen-dependent tissues: I. Dose-response and time-course evaluation. Endocrinology 129:7177251991Rahimy MH Anderson WR Brewster ME et al: The effects of a brain-enhanced estradiol delivery system on testosterone and androgen-dependent tissues: I. Dose-response and time-course evaluation. Endocrinology 129:717–725 1991

    • Search Google Scholar
    • Export Citation
  • 30.

    Rahimy MHSimpkins JWBodor N: Dose and time-course evaluation of a redox based estradiol-chemical delivery system for the brain. I. Tissue distribution. Pharmaceut Res 7:106110671990Rahimy MH Simpkins JW Bodor N: Dose and time-course evaluation of a redox based estradiol-chemical delivery system for the brain. I. Tissue distribution. Pharmaceut Res 7:1061–1067 1990

    • Search Google Scholar
    • Export Citation
  • 31.

    Rahimy MHSimpkins JWBodor N: Dose and time-course evaluation of a redox-based estradiol-chemical delivery system for the brain. II. Pharmacodynamic responses. Pharmaceut Res 7:110711121990Rahimy MH Simpkins JW Bodor N: Dose and time-course evaluation of a redox-based estradiol-chemical delivery system for the brain. II. Pharmacodynamic responses. Pharmaceut Res 7:1107–1112 1990

    • Search Google Scholar
    • Export Citation
  • 32.

    Shamma FNFayan PBrass Let al: Middle cerebral artery blood velocity during controlled ovarian hyperstimulation. Fertil Steril 57:102210251992Shamma FN Fayan P Brass L et al: Middle cerebral artery blood velocity during controlled ovarian hyperstimulation. Fertil Steril 57:1022–1025 1992

    • Search Google Scholar
    • Export Citation
  • 33.

    Simpkins JWGreen PSGridley KEet al: Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer's disease. Am J Med (In press 1997)Simpkins JW Green PS Gridley KE et al: Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer's disease. Am J Med (In press 1997)

    • Search Google Scholar
    • Export Citation
  • 34.

    Simpkins JWSingh MBishop J: The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer's disease. Neurobiol Aging 15(Suppl 2):S195S1971994Simpkins JW Singh M Bishop J: The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer's disease. Neurobiol Aging 15 (Suppl 2):S195–S197 1994

    • Search Google Scholar
    • Export Citation
  • 35.

    Singer CAStrickland TMRogers KLet al: Estrogen protects primary cortical neurons from glutamate neurotoxicity. Soc Neurosci Abstr 21:8821995Singer CA Strickland TM Rogers KL et al: Estrogen protects primary cortical neurons from glutamate neurotoxicity. Soc Neurosci Abstr 21:882 1995

    • Search Google Scholar
    • Export Citation
  • 36.

    Singh MMeyer EMMillard WJet al: Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Res 644:3053121994Singh M Meyer EM Millard WJ et al: Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Res 644:305–312 1994

    • Search Google Scholar
    • Export Citation
  • 37.

    Stampfer MJColditz GAWillett WCet al: Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurse's health study. N Engl J Med 325:7567621991Stampfer MJ Colditz GA Willett WC et al: Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurse's health study. N Engl J Med 325:756–762 1991

    • Search Google Scholar
    • Export Citation
  • 38.

    Wren BG: The effect of oestrogen on the female cardiovascular system. Med J Aust 157:2042081992Wren BG: The effect of oestrogen on the female cardiovascular system. Med J Aust 157:204–208 1992

    • Search Google Scholar
    • Export Citation
TrendMD
Cited By
Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 403 387 58
Full Text Views 206 87 3
PDF Downloads 98 31 2
EPUB Downloads 0 0 0
PubMed
Google Scholar